News

What’s driving growth in the endocannabinoid therapeutics sector?
A range of factors are coming together to the sector's benefit.
Read more
Significant Exits in the Global MedCan Market
A number of multi billion dollar exits in the sector show the viability and potential of early stage…
Read more
Óskare’s 2022 market predictions come to fruition
Óskare Capital correctly called a range of key sector events in 2022.
Read more
Family Offices Boost Private Equity Investment For 2023
North American family offices are increasing private equity portfolio allocation in 2023.
Read more
How Medical Cannabis is Revolutionising Chronic Pain Management
Medical cannabis is providing doctors with a range of new treatments for chronic pain conditions.
Read more
Germany’s plan for legalisation flips its current supply model
Germany’s plan for legalisation changes its current supply model
Read more
Stopping new investments? Think again…
Fund allocations in a bear market
Read more
Medical Cannabis EIS and SEIS Fund Launched
The MEDCAN Fund has launched today
Read more
ÓSKARE CAPITAL QUARTERLY NEWSLETTER
APRIL 2021
Read more
Guest Post: The Symbiosis of Regulation and Science – Óskare Capital SAS
ÓSKARE Fund I & Medical Cannabinoids
Read more